Myriad ( Myriad )

Myriad

Myriad's picture

Myriad is dedicated to providing patients and physicians with clinically important information globally. As part of this, Myriad has established International Headquarters in Zurich, Switzerland, a full service laboratory in Munich, Germany and sales offices in Munich, Germany, Paris, France, Madrid, Spain, Milan, Italy and Zurich, Switzerland. Additionally, we are working with a number of distributors globally.

Myriad press release, blog etc

06/18/2018 - 13:40 Myriad's BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer
06/06/2018 - 03:52 Crescendo Bioscience Announces Four Studies with Vectra DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
06/01/2018 - 10:44 Myriad Genetics Presents Second Pivotal Validation Study for riskScore Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
05/31/2018 - 13:13 Myriad Genetics to Present at Two Upcoming Investor Conferences
05/31/2018 - 13:06 GeneSight Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
05/28/2018 - 16:04 Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.
05/23/2018 - 15:04 Myriad Announces Seven New Payer Coverage Decisions for Prolaris
05/15/2018 - 05:25 Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting
05/07/2018 - 02:28 Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
05/04/2018 - 05:05 Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
05/02/2018 - 06:52 Myriad Genetics Named to Forbes 2018 List of America's Best Midsize Employers
04/27/2018 - 07:45 New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing
04/19/2018 - 04:39 Myriad Announces Launch of "Go Green" Sustainability Initiative In Support of Earth Day
04/02/2018 - 05:24 Myriad Receives Pre-Market Approval for its BRACAnalysis Diagnostic System in Japan
03/06/2018 - 07:10 Myriad Applauds AACU Position Statement on Molecular Testing for Risk Stratification in Prostate Cancer
03/01/2018 - 02:58 Myriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness Month
02/20/2018 - 04:34 NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer
02/15/2018 - 13:24 JAMA Oncology Publication Demonstrates EndoPredict (EPClin) Significantly Outperforms Oncotype DX Recurrence Score in Early-Stage Breast Cancer